MedPath

NanoPin Technologies, Inc.

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website
https://www.nanopintech.com

Clinical Evaluation of the NanoDetect-TB Mycobacterium Tuberculosis Detection Kit for the Diagnosis of Tuberculosis Disease

Not yet recruiting
Conditions
Tuberculosis, Extrapulmonary
Tuberculosis Active
Tuberculosis, Pulmonary
Interventions
Device: NanoDetect-TB
First Posted Date
2023-08-08
Last Posted Date
2023-08-08
Lead Sponsor
NanoPin Technologies, Inc.
Target Recruit Count
460
Registration Number
NCT05981495
© Copyright 2025. All Rights Reserved by MedPath